Tuesday 31 December 2019

Mindfulness training may lower blood pressure


Long believed to be a calming activity, a new study provides evidence of the benefits of mindfulness in reducing high blood pressure.
There is anecdotal evidence that meditation and mindfulness training may be able to reduce high blood pressure and hypertension. However, clinical confirmation of these claims has been scarce until last month, when researchers published a new study in the journal PLOS One.
The authors report the results of a Mindfulness-Based Blood Pressure Reduction (MB-BP) program specifically designed to "evaluate acceptability, feasibility, and effects on hypothesized proximal self-regulation mechanisms."
Participants who enrolled in the MB-BP program experienced significant reductions in blood pressure levels that were still in effect at follow-up examinations 1 year after the trial.
Hypertension is a significant risk factor for heart disease, which is the leading cause of death in the United States and globally. However, doctors can find hypertension challenging to treat.
"We know enough about hypertension that we can theoretically control it in everybody — yet in about half of all people diagnosed, it is still out of control," according to lead author Eric Loucks, associate professor of epidemiology, behavioral and social sciences, and medicine at Brown University in Providence, RI.
The blood pressure challenge and MB-BP
When doctors diagnose someone with high blood pressure, they typically recommend more healthful eating, which includes reducing salt intake, as well as regular exercise and weight loss. However, some people may find such permanent lifestyle changes difficult to maintain. Doctors might also prescribe medication to help control blood pressure.
In some people, hypertension has a genetic component, and lifestyle changes do not bring blood pressure down into the normal range.
Top of Form
Bottom of Form
The MP-BP curriculum incorporates mindfulness to address high blood pressure directly and to help people strengthen their ability to maintain the healthful habits that can keep it under control.
Loucks and his colleagues developed a 10-session program that followed 43 participants with high or elevated blood pressure for 1 year. More than 80% of participants had hypertension, with blood pressure readings of 130 millimeters of mercury (mmHg) systolic over 85 mmHg diastolic or higher. The other people had systolic readings of between 120 mmHg and 130 mmHg, with a diastolic measurement of at least 80 mmHg.
According to Loucks, the program was "a deliberately multimodal intervention" that taught participants a variety of techniques. These included mindfulness training and explanations of how behaviors can contribute to high blood pressure. They also encouraged the participants to take medications as prescribed by their doctors consistently.
The effect of the MB-BP curriculum
After 1 year, the participants' blood pressure was still lower than at baseline. In addition, their self-management skills remained strong. Participants who had struggled to follow healthful lifestyle recommendations before the study had maintained lifestyle changes.
The participants who benefited most from the program were those with stage 2 uncontrolled hypertension, which is characterized by a systolic measurement of over 140 mmHg. These participants saw a mean reduction in their blood pressure of 15.1 mmHg.
Additional testing is now underway through a randomized control trial involving a larger cohort of 200 participants. "Future trials," Loucks says, "could involve a dismantling study, where we would take out some of the health education, for example, and see if mindfulness training still had significant effects. That's certainly something we're looking at doing in the long-term. But mindfulness training is usually designed to be integrated with standard medical care."
Loucks is hopeful that the study's results can change lives: "I hope that these projects will lead to a paradigm shift in terms of the treatment options for people with high blood pressure."
"The hope is that if we can start mindfulness training early in life, we can promote a trajectory of healthy aging across the rest of people's lives. That will reduce their chances of getting high blood pressure in the first place."



Monday 30 December 2019

Cholesterol levels in young adults can predict heart disease risk


A recent study investigates the relationship between cholesterol levels in young adulthood and cardiovascular risk in later life — with interesting recommendations for further research.
Research has already well documented that high cholesterol levels can lead to heart disease, the leading cause of death in the United States, and stroke, the fifth leading cause of death.
Cholesterol is a fatty substance that the liver and foods we eat, such as eggs, cheese, and certain meat products produce.
Cholesterol is necessary for the body to function. However, too much "bad" cholesterol, which is also called low-density lipoprotein (LDL), can clog the arteries with a fatty buildup, increasing the risk of heart attack, stroke, or peripheral artery disease.

Scientists have also linked high total cholesterol to overweight, lack of exercise, smoking, and alcohol consumption.
More than 12% of adults in the U.S. aged 20 years and over have total cholesterol levels above 240 milligrams per deciliter (mg/dl), which doctors consider high. Of children and adolescents aged 6–19 years, some 7% have high total cholesterol.
High-density lipoprotein (HDL) is "good" cholesterol and helps to sweep LDL from the arteries back to the liver, which removes it from the body.
A long look at lipids
A new, comprehensive study, appearing in The Lancet, follows almost 400,000 people in 19 countries for up to 43.5 years (1970–2013). The findings shine a spotlight on the link between bad cholesterol (non-HDL) levels in people under 45 years of age and the long-term risk of heart disease and stroke.
Set apart from previous studies, this observational and modeling study, which looked at individual level data, suggests that elevated non-HDL cholesterol levels at a younger age can predict cardiovascular risk at 75 years of age.
The study used data from 38 studies carried out in the U.S., Europe, and Australia.
Of the nearly 400,000 individuals that the study followed, none had cardiovascular disease at the start. The scientists tracked the participants over decades and took details of any heart disease event, fatal or otherwise, or stroke.
In total, there were 54,542 incidents of heart disease, fatal or non-fatal, and stroke.
When researchers analyzed the data for all age groups and both sexes, they saw that the risk of heart disease or stroke dropped continuously as non-HDL levels dropped. In fact, those with the lowest non-HDL levels, — which the scientists defined as 2.6 millimoles (mmol) non-HDL cholesterol per liter — had the least risk.
Top of Form
Bottom of Form
The highest long-term risks of heart and artery disease were in those younger than 45 years old.
"This increased risk in younger people could be due to the longer exposure to harmful lipids in the blood," says Prof. Barbara Thorand, of the German Research Center for Environmental Health in Neuherberg.
Study suggests early intervention vital
The study confirmed that the level of non-HDL and HDL cholesterol in the blood played a significant part in predicting the risk of cardiovascular disease over time.
Researchers used data to create a model for people aged 35–70 years that could estimate the chances of a heart event by age 75 years. It factored in sex, age, non-HDL levels, and cardiovascular risk factors, such as blood pressureBMIdiabetes, and smoking status.
It also examined how much one could lower risk if non-HDL cholesterol levels were a hypothetical 50% lower. Using this approach, the researchers saw the most significant reduction in risk in the youngest age group.
As an example, a male under 45 years of age has starting levels of non-HDL cholesterol of between 3.7–4.8 mmol per liter and at least two risk factors for cardiovascular disease; if the individual was to halve their levels of non-HDL cholesterol, they could reduce the risk from 16% to 4%.
A female with the same factors could reduce their risk from around 29% to 6%.
Using the same levels of non-HDL cholesterol in individuals of 60 years or more, males could reduce risk from 21% to 10%, and females from 12% to 6%.
The researchers suggest that intensive efforts to lower non-HDL cholesterol levels could reverse early signs of blocked arteries, which is known as atherosclerosis.
However, there was no clarity on how much slightly increased or seemingly normal cholesterol levels affected cardiovascular risk over a person's lifetime or at what level treatment recommendations should occur, especially in younger adults.
"Our estimates suggest that halving non-HDL cholesterol levels may be associated with reduced risk of cardiovascular events by the age of 75 years and that this reduction in risk is larger the sooner cholesterol levels are reduced."
Co-author Prof. Stefan Blankenberg
"The risk scores currently used in the clinic to decide whether a person should have lipid-lowering treatment only assess the risk of cardiovascular disease over 10 years, and so may underestimate lifetime risk, particularly in young people," notes the study's co-author, Prof. Stefan Blankenberg.
The authors say future research is needed to understand whether early intervention in younger people with low 10-year risk but high lifetime risk would have more benefits than later intervention.
A limitation of the study is that it may not apply to all regions or ethnic groups because its focus was on high income countries.


Source: Medical News Today

Sunday 29 December 2019

6 innovations from Future Healthcare 2019




T
his week, Medical News Today attended the Future Healthcare Exhibition and Conference. Delegates presented us with technology, both new and old, destined to push healthcare forward.
Share on Pinterest
Future Healthcare is an annual event that takes place in London in the United Kingdom.
It is a showcase of international innovation in the healthcare space. This year, over 350 brands attended.
We spent much of our time listening to short introductions to new products in the Health Innovators Theatre.
They all had the potential to change the way that healthcare professionals deliver and monitor healthcare.
As ever, data and the way experts manipulate them featured heavily. As one presenter asked, "Data [are] the answer, what is the question?"
However, there were also companies attempting to reinvent old technologies using a fresh approach.
ADVERTISING
Below is a brief introduction to some of the products that piqued our interest this year.
1. Detecting dementia early
Today, Alzheimer's disease — the most common form of dementia — is one of the leading causes of death in the United States. As the population's average age slowly rises, the number of deaths due to dementia are likely to rise in line.
Despite this, catching dementia early remains challenging. Oxford Brain Diagnostics believe that their technology can catch the condition years before symptoms become apparent.
Their secret lies in cortical disarray measurement (CDM). In short, this technique enables scientists to gather an "extra level of detail" from existing MRI scans. This allows them to detect changes in the microanatomy of the brain.
Dr. Steven Chance — Oxford Brain Diagnostics' CEO — told MNT that "CDM extracts information about the microscopic structure of the brain's gray matter by applying a unique analysis to a standard form of MRI scan."
"The method reveals the damage to the cerebral cortex even in the early stages of disease because it is sensitive to disruption at the cellular scale."
Dr. Steven Chance
Alongside the obvious benefits of spotting the signs of dementia earlier, the technology might also assist the pharmaceutical industry: Researchers could quantify how experimental drugs affect the microstructure of the brain.
2. Blockchain for health
Healthcare has always been about the patient, of course. However, in recent years, there has been an increasing push to involve the patient more deeply. Particularly, there has been discussion around how doctors store our data, who keeps them, and how they are shared.
Medicalchain want to change how people access their medical records. By using secure blockchain technology — most famous for its use in cryptocurrency — they have designed a way that patients can view and, when necessary, share their data with clinicians. Medicalchain have outlined their product in a white paper:
"Medicalchain enables the user to give healthcare professionals access to their personal health data. Medicalchain then records interactions with [these] data in an auditable, transparent, and secure way on Medicalchain's distributed ledger."
This technology, the company believes, would empower the patient. Also, as online consultations become more popular, this technology would help overcome some of their inherent privacy and security issues.
The company hope that soon, their services could be open to the public at large.
3. Mobile cancer screening
In 2018, globally, there were 570,000 new cases of cervical cancer. Around 90 percent of deaths from cervical cancer occur in low- and middle-income societies.
Share on PinterestThe hand-held EVA System.
Better screening and earlier intervention could significantly reduce the mortalty rate.
MobileODT have designed a battery-powered, hand-held colposcope called the EVA System, which can take high-quality images of the cervix.
MobileODT worked with the National Cancer Institute to develop a machine learning algorithm, called automatic visual evaluation (AVE), that can produce an accurate diagnosis in minutes.
A prospective, multicenter pilot study that scientists conducted in Korea showed that the device is more than 90 percent accurate.
Top of Form
MEDICAL NEWS TODAY NEWSLETTER
Stay in the know. Get our free daily newsletter
Expect in-depth, science-backed toplines of our best stories every day. Tap in and keep your curiosity satisfied.
SIGN UP NOW
Your privacy is important to us
Bottom of Form
Yael Misrahi — head of global partnerships at MobileODT — outlined the product at Future Healthcare. MNT caught up with her after the event, and she explained that one of the primary benefits of this system is that "it is handheld and can be used by a nonexpert healthcare provider."
Because the device is based on smartphone technology, it is user-friendly and includes a "remote consultation feature to consult experts either in real-time or during a quality assurance check."
"[W]ith AVE — the machine learning algorithm for detection of pre-cancer — there is no need for a scrape or a lab and a woman is able to receive a result at the point of care rather than waiting several weeks or months for a result."
Yael Misrahi
4. Upgrading disposable batteries
How batteries work has remained relatively unchanged for decades. BlueThink — without altering the underlying chemistry — have developed a way of making a common type of battery safer and more cost-effective.
Share on PinterestBlueThink's battery is compact, simply constructed, flexible, and safe.
Manufacturers now widely use button batteries in medical devices, as BlueThink's Javier Eduardo Nadal explained to MNT:
"Medical devices are now smarter and more user-friendly than ever before."
"This growing trend relies on good design and the use of technologies like LEDs and screens to improve the user experience, as well as connectivity to provide patients, doctors, and healthcare systems with valuable data."
"All these innovative devices have one thing in common: They need energy."
Button batteries are not without their problems; if a person leaves them on a shelf for a long time, they lose their charge. If they are incinerated — for instance, those of contaminated disposable medical equipment — they explode.
They are also harmful to the environment and a significant hazard for children if swallowed.
According to BlueThink, they have found a way to mitigate all of the above. Using standard battery technology but with a twist, they have created a flexible battery that a child could safely swallow, that does not explode when incinerated, and that keeps its charge when left on a shelf.
Importantly, it is also low-cost and producible in large quantities.
Nadal told MNT that "[a] small amount of energy can make a big difference in a medical device, but it must not compromise user experience, safety, or sustainability."
5. Robots vs. loneliness
Loneliness is a real, increasing issue in the U.S. and globally. In fact, many healthcare professionals now recognize loneliness as a risk factor for a number of medical conditions, including cardiovascular disease.
Share on PinterestGenie Connect promises to combat loneliness.
For this reason, we need to address loneliness with urgency.
Service Robotics Limited have recently created an innovative solution that aims to bridge this gap.
Genie Connect is a friendly looking miniature robot. The designers described it as "a companion robot service that uses a friendly, intuitive, voice-enabled robot to offer connectivity and support [...] older adults."
It can carry out commands in a similar way to other popular virtual assistants, but it has a range of bespoke, customizable features.
Genie Connect can have a conversation and set up video chats with healthcare professionals and family members. Service Robotics Limited designed it to help stimulate and engage the user's mind. It also reminds the user when to take medication and attend appointments.
There is a common concern that robots will take away the jobs of humans; in this case, Genie Connect fills a gap that humans currently leave open.
6. Breathe more easily?
Perhaps the most unusual device we saw at Future Healthcare 2019 was called SoeMac. According to its creators, "SoeMac alternative therapy creates energized oxygen, which your body can safely use to help restore itself at night while you sleep."
SoeMac is a small, rectangular device that gently whirrs. A user simply switches it on and leaves it by their bed at night. According to the designers, it helps us breathe more easily and sleep better.
They say that "it works by drawing air inside and producing a bio-usable form of energized oxygen, known as Singlet Oxygen Energy, or SOE."
"This can help your body to carry out essential restorative work while you sleep at night, boosting the effectiveness of your nighttime detoxification and bodily repair functions."
It is crucial to note that so far, no clinical trials back up these claims. However, SoeMac's creators are planning studies in the near future. In particular, they hope that it might give relief to people with chronic obstructive pulmonary disease.
Overall, Future Healthcare 2019 was a thoroughly interesting event. It is always exciting being party to the cutting edge of medical innovation.

Source: MedicalNewsToday

Saturday 28 December 2019

2019 in medical research: What were the top findings?




A
nother busy year for clinical research has come and gone. What are the most important findings from 2019? Here is our overview of some of the most noteworthy studies of the year.
Share on PinterestWhat happened in medical research in 2019? In this special feature, we summarize this year's top findings.
"Medicine is of all the Arts the most noble," wrote the Ancient Greek physician Hippocrates — whom historians call the "father of medicine" — over 2,000 years ago.
Advances in therapeutic practices have been helping people cure and manage illness since before the time of Hippocrates, and, today, researchers continue to look for ways of eradicating diseases and improving our well-being and quality of life.
Each year, specialists in all areas of medical research conduct new studies and clinical trials that bring us a better understanding of what keeps us happy and in good health, and what factors have the opposite effect.
And, while each year, experts manage to overcome many obstacles, challenges old and new keep the medical research field buzzing with initiatives.
Reflecting on how research has evolved over the past decade, the editors of the reputable journal PLOS Medicine — in a recent editorial — emphasize "ongoing struggles" with infectious diseases, as well as growing tensions between two approaches in medical research. These approaches are the effort of finding treatments that are consistently effective in large populations versus the notion of "precision medicine," which favors therapy that we closely tailor to an individual's very personal needs.
But how has clinical research fared in 2019? In this special feature, we look at some of the most prominent areas of study from this year and give you an overview of the most noteworthy findings.
Friends or foes?
The medication we take — as long as we follow our doctors' advice — is meant to help us fight off disease and improve our physical or mental well-being. But can these usually trusty allies sometimes turn into foes?
Most drugs can sometimes cause side effects, but more and more studies are now suggesting a link between common medication and a higher risk of developing different conditions.
In March this year, for instance, experts affiliated with the European Resuscitation Council — whose goal is to find the best ways to prevent and respond to cardiac arrest — found that a conventional drug doctors use to treat hypertension and angina may actually increase a person's risk of cardiac arrest.
By analyzing the data of more than 60,000 people, the researchers saw that a drug called nifedipine, which doctors often prescribe for cardiovascular problems, appeared to increase the risk of "sudden cardiac arrest."
Project leader Dr. Hanno Tan notes that, so far, healthcare practitioners have considered nifedipine to be perfectly safe. The current findings, however, suggest that doctors may want to consider offering people an alternative.
Another study, appearing in JAMA Internal Medicine in June, found that anticholinergic drugs — which work by regulating muscle contraction and relaxation — may increase a person's risk of developing dementia.
People may have to take anticholinergics if some of their muscles are not working correctly, usually as part of health issues, such as bladder or gastrointestinal conditions, and Parkinson's disease.
The research — that specialists from the University of Nottingham in the United Kingdom led — looked at the data of 58,769 people with and 225,574 people without dementia.
It revealed that older individuals — at least 55 years old — who were frequent users of anticholinergics were almost 50% more likely to develop dementia than peers who had never used anticholinergics.
But, while common drugs that doctors have prescribed for years may come with hidden dangers, they are, at least, subject to trials and drug review initiatives. The same is not true for many other so-called health products that are readily available to consumers.
Such findings says the study's lead researcher, Prof. Carol Coupland, "highlight the importance of carrying out regular medication reviews."
In 2019, we have celebrated 50 years since someone first successfully sent a message using a system that would eventually become the internet. We have come a long way, and now, we have almost everything within reach of a "click and collect" order.
This, unfortunately, includes "therapeutics" that specialists may never have assessed, and which can end up putting people's health — and lives — in danger.
In August, the Food and Drug Administration (FDA) issued a warning against an allegedly therapeutic product that was available online, and which appeared to be very popular.
The product — variously sold under the names Master Mineral Solution, Miracle Mineral Supplement, Chlorine Dioxide Protocol, or Water Purification Solution — was supposed to be a kind of panacea, treating almost anything and everything, from cancer and HIV to the flu.
Yet the FDA had never given the product an official assessment, and when the federal agency looked into it, they saw that the "therapeutic" — a liquid solution — contained no less than 28% sodium chlorite, an industrial bleach.
"[I]ngesting these products is the same as drinking bleach," which can easily be life threatening, warned the FDA's Acting Commissioner Dr. Ned Sharpless, who urged people to avoid them at all costs.
The heart and its tributaries
Many studies this year have also been concerned with cardiovascular health, revisiting long held notions and holding them up to further scrutiny.
For instance, a study in the New England Journal of Medicine in July — which involved around 1.3 million people — suggested that, when it comes to predicting the state of a person's heart health, both blood pressure numbers are equally important.
When a doctor measures blood pressure, they assess two different values. One is systolic blood pressure, which refers to the pressure the contracting heart puts on the arteries when it pumps blood to the rest of the body. The other is diastolic blood pressure, which refers to the pressure between heartbeats.
So far, doctors have primarily taken only elevated systolic blood pressure into account as a risk factor for cardiovascular disease.
However, the new study concluded that elevated systolic and diastolic blood pressure are both indicators of cardiovascular problems.
Its authors emphasize that the large amount of data they had access to painted a "convincing" picture in this respect.
"This research brings a large amount of data to bear on a basic question, and it gives such a clear answer."
Lead researcher Dr. Alexander Flint
At the same time, a slightly earlier study, appearing in the European Heart Journal in March, emphasizes that having high blood pressure may not mean the same thing for everyone, and while doctors may associate it with adverse outcomes in some, this does not hold for all populations.
The study's first author, Dr. Antonio Douros, argues that "[w]e should move away from the blanket approach of applying the recommendations of professional associations to all groups of patients."
Dr. Douros and team analyzed the data of 1,628 participants with a mean age of 81 years. The researchers found that older individuals with lower systolic blood pressures actually faced a 40% higher risk of death than peers with elevated blood pressure values.
"[A]ntihypertensive [blood pressure lowering] treatment should be adjusted based on the needs of the individual," the study's first author advises.
When it comes to protecting heart health, 2019 studies have shown that diet likely plays an important role. Thus, research in the Journal of the American Heart Association in August showed that people who adhered to plant-based diets had a 32% lower risk of death that researchers associate with cardiovascular disease than those who did not.
People who ate plant-based foods also had a 25% lower risk of all-cause mortality, according to this study.
And another study — from April in the journal Nutrients — warned that people who follow a ketogenic diet, which is high in fats and low in carbohydrates, and who decide to take a "day off" from this commitment every now and again, may experience blood vessel damage.
Ketogenic — or keto — diets work by triggering ketosis, a process in which the body starts burning fat instead of sugar (glucose) for energy. But "cheat days" mean that, for a brief interval, the body switches back to relying on glucose.
"[W]e found [...] biomarkers in the blood, suggesting that vessel walls were being damaged by the sudden spike in glucose," notes first author Cody Durrer.
Our diets, ourselves
In 2019, the topic of how our food choices influence our health has remained popular among researchers and readers alike.
According to Google Trends, some of the top searches in the United States this year included intermittent fasting diets, the Noom diet, and the 1,200 calorie diet.
And this year's studies have certainly reflected the widespread interest in the link between dietary choices and well-being.
One intriguing study — in Nature Metabolism in May — pointed out that protein shakes, which are popular among individuals who want to build muscle mass, may be a threat to health.
Fitness protein powders, the study authors explain, contain mostly whey proteins, which have high levels of the essential amino acids leucine, valine, and isoleucine.
The research — in mice — suggested that a high intake of these amino acids led to overly low levels of serotonin in the brain. This is a key hormone that plays a central role in mood regulation, but which science also implicates in various metabolic processes.
In mice, the heightened levels of leucine, valine, and isoleucine, which caused excessively low serotonin, led to obesity and a shorter life span.
So, if too much of certain types of protein can have such detrimental effects on health, what about fiber? Dietary fiber — present in fruit, vegetables, and legumes — is important in helping the body take up sugars little by little.
But how much fiber should we consume? This is the question that a study commissioned by the World Health Organization (WHO) — and appearing in The Lancet in January — sought to lay to rest.
The research took into account the findings of 185 observational studies and 58 clinical trials, covering almost 40 years.
It concluded that to lower their death risk, as well as the incidence of coronary heart disease, stroke, type 2 diabetes, and colon cancer, a person should ideally consume 25–29 grams of fiber per day.
"Fiber-rich whole foods that require chewing and retain much of their structure in the gut increase satiety and help weight control and can favorably influence lipid and glucose levels," explains one of the authors, Prof. Jim Mann.
On the other hand, several studies from this year draw attention to just how detrimental foods that are not 100% natural can be. A small trial, whose results came out in Cell Metabolism in May, showed that processed food leads to abrupt weight gain — but not for the reasons we may think.
The study authors said they were surprised that when they asked participants to eat either an ultraprocessed food diet or a nonprocessed food diet — whose caloric contents the researchers matched perfectly — the people who ate processed foods rapidly gained more weight than the ones who ate the nonprocessed foods.
The researchers blame this on the speed with which individuals end up eating processed foods, in particular. "There may be something about the textural or sensory properties of the food that made [participants] eat more quickly," says study author Kevin Hall, Ph.D.
"If you're eating very quickly, perhaps you're not giving your gastrointestinal tract enough time to signal to your brain that you're full. When this happens, you might easily overeat," he hypothesizes.
And more research in mice — from Scientific Reports in January — found that emulsifiers, which are a common additive present in many products from mayonnaise to butter, could affect gut bacteria, leading to systemic inflammation.
What is more, the impact on the gut could even influence processes that occur in the brain, increasing anxiety levels. "[W]e [now] know that inflammation triggers local immune cells to produce signaling molecules that can affect tissues in other places, including the brain," explains co-lead researcher Prof. Geert de Vries.
While some of the studies that made the headlines in 2019 were conclusive, many encourage further research to confirm their findings or further investigate the underlying mechanisms.
Stepping into the next decade, this much is clear: The wheels of medical research will keep on turning for better health across the globe.

Source: MedicalNewsToday